News ImmuCell Corporation

Stocks

ICCC

US4525253062

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 06:00:00 17/06/26 am AEST			5-day change	1st Jan Change
9.380 ^USD	-1.57%		-3.99%	+52.52%

16/05	ImmuCell Corporation, Q1 2026 Earnings Call, May 15, 2026
15/05	ImmuCell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

All News

Mentions Relevance

16/05	ImmuCell Corporation, Q1 2026 Earnings Call, May 15, 2026
15/05	ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026	AQ
15/05	ImmuCell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
09/05	ImmuCell, Norbrook enter settlement deed on May 8, 2026 - SEC filing	RE
08/05	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026	AQ
22/04	ImmuCell : Corporate Presentation (Investor Relations April 2026 Final)	PU
14/04	ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors	AQ
14/04	ImmuCell Corporation Announces Board Changes	CI
09/04	ImmuCell Q1 Sales Jump; Shares Rise After Hours	MT
09/04	ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results	AQ
09/04	Immucell Corporation Announces Preliminary, Unaudited Sales Results for the Firs Quarter of 2026	CI
19/03	Immucell Corporation Announces Changes to Its Board, Effective April 1, 2026	CI
19/03	ImmuCell : 03-18-26 – ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board	PU
19/03	ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board	AQ
06/03	ImmuCell Corporation, Q4 2025 Earnings Call, Mar 05, 2026
05/03	ImmuCell Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
05/03	ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025	AQ
19/02	ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025	AQ
10/02	Steven A. Rosgen and Bryan K. Gathagan Have Decided Not to Seek Re-Election as Directors of ImmuCell Corporation	CI
10/01	ImmuCell Corporation, Q4 2025 Sales/ Trading Statement Call, Jan 09, 2026
09/01	ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025	AQ
09/01	Immucell Corporation Announces Preliminary, Unaudited Sales Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
08/01	ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus	AQ
25/12	ImmuCell Pauses Investment in Cow Mastitis Drug After Receiving FDA Incomplete Letter	DJ
25/12	ImmuCell pauses investment in Re-Tain	RE